Xencor Inc logo

Xencor Inc

XNCR
Healthcare|Biotechnology|USA
$15.86
-0.27 (-1.64%)
Tangible Book
$6.86

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 77.89, 120.35, 140.67, 269.82, 539.16 ], "ebit_estimate": [ -272.48, -285.17, -297.46, -213.74, -93.95 ], "ebitda_estimate": [ -264.39, -285.26, -281.42, -89.04, -87.35 ], "net_income_estimate": [ -298.27, -265.36, -296.25, -224.39, -80.4 ], "per_share_eps_estimate": [ -3.83, -3.16, -3.18, -1.99, -0.2 ], "eps_nri_estimate": [ -3.95, -3.23, -3.18, -1.99, -0.2 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -305.39, -284.17, -296.07, -201.17, -78.66 ], "operating_cash_flow_per_share_estimate": [ -1.84, -1.27, null, null, null ], "roa_estimate": [ -46.9, -61.2, null, null, null ], "roe_estimate": [ -31.86, -89.4, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, 93.33, 93.27 ], "operating_cash_flow_estimate": [ -138.45, -95.56, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": -29.97, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -30.09, "future_eps_nri_estimate_growth": -29.97, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -17.29, "future_ebitda_estimate_growth": -17.84, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -40.31, "future_pretax_income_estimate_growth": -42.09, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 20.06, 22.64, 30.96, 13.14, 13.29, 13.79, 14.02, 14.71 ], "ebit_estimate": [ -64.14, -64.73, -64.78, -70.04, -73.73, -75.86, -78.65, -64.8 ], "ebitda_estimate": [ -65.6, -65.17, -64.18, -63.73, -63.64, -63.7, -63.72, -62.24 ], "net_income_estimate": [ -61.42, -60.12, -52.92, -70.46, -74.28, -76.62, -79.55, -64.8 ], "per_share_eps_estimate": [ -0.79, -0.77, -0.65, -0.84, -0.85, -0.91, -0.98, -0.71 ], "eps_nri_estimate": [ -0.81, -0.79, -0.67, -0.87, -0.88, -0.94, -1.01, -0.82 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -61.51, -60.99, -56.47, -70.46, -74.28, -76.62, -79.55, -64.8 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, 100, 100, 100, 100 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": -29.97, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -30.09, "future_eps_nri_estimate_growth": -29.97, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -17.29, "future_ebitda_estimate_growth": -17.84, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -40.31, "future_pretax_income_estimate_growth": -42.09, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-07 13:07:23
2026-06-22 22:01:14
2026-06-17 22:03:51